한국판 약물 순응척도의 표준화 연구 = The Reliability and Validity of the Korean Version of Medication Adherence Rating Scale

다국어 초록 (Multilingual Abstract)

Objective Finding out patient’s non-adherence to medication is an important work for treating schizophrenia. The Medication Adherence Rating Scale is a self-report form, which can simply measure medication adherence in psychosis. We evaluated the reliability and validity of the Korean version of Medication Adherence Rating Scale (KMARS).
Methods Eighty-one individuals with schizophrenia completed the self-administered questionnaires including KMARS, Brief Adherence Rating Scale (BARS), Korean version of Drug Attitude Inventory-10 (KDAI-10) and Korean version of Medication Adherence Questionnaire (KMAQ). Psychometric properties of the KMARS were analyzed.
Results The KMARS has an acceptable internal consistency (α=0.71). The KMARS total scores are moderately correlated with BARS (r=0.44, p<0.01), KDAI-10 (r=0.55, p<0.01) and KMAQ (r=0.62, p<0.01). As the result of factor analysis, the structure of the KMARS is different from original scale, but the KMARS can assess not only adherence behavior but also subjective response to medication. Among the questions item 5, “I take my medication only when I am sick”, should be used carefully, because it has ambiguous meaning in Korean.
Conclusion KMARS is a simple and reliable tool for measuring medication adherence in psychosis.

국문 초록 (Abstract)

본 연구는 KMARS의 표준화 연구로서 KMARS는 양호한 신뢰도와 공존 타당도를 가진 유용한 순응도 평가 도구인 것으로 검증되었다. 요인 분석 결과 KMARS는 순응행동, 약물에 대한 반응, 약물에 대한 태도의 3가지 요인으로 구성되어 순응도에 영향을 미치는 다양한 요소들을 고려하여 순응도를 평가할 수 있다. 문항 중 ‘나는 아플 때만 약을 먹는다’는 중의적 의미를 갖기 때문에 사용에 주의가 필요하다. KMARS는 시간적 여유가 부족한 외래환경에서 환자의 순응도를 확인하는 편리한 평가 도구로서 활용이 기대된다.

참고문헌 (Reference)

1 윤보현, "한국판 약물태도 척도의 심리측정적 특성" 대한정신약물학회 16 (16): 480-487, 2005

2 Byerly MJ, "Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia" 58 : 844-847, 2007

3 Misdrahi D, "Therapeutic adherence and schizophrenia: the interest of the validation of the French translation of Medication Adherence Rating Scale (MARS)" 30 : 409-410, 2004

4 Velligan DI, "The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness" 70 (70): 1-46, 2009

5 Byerly MJ, "The Brief Adherence Rating Scale(BARS)validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder" 100 : 60-69, 2008

6 Yi JS, "Reliability and validity of the Korean version of global assessment of functioning scale" 6 : 118-124, 2003

7 Thompson K, "Reliability and validity of a new Medication Adherence Rating Scale(MARS)for the psychoses" 42 : 241-247, 2000

8 Kane JM, "Problems of compliance in the outpatient treatment of schizophrenia" 44 (44): 3-6, 1983

9 Babiker IE, "Noncompliance in schizophrenia" 4 : 329-337, 1986

10 Vanelli I, "Medication adherence rating scale" 24 : 17-20, 2011

11 Verdoux H, "Medication adherence in psychosis: predictors and impact on outcome. A 2-year follow-up of first-admitted subjects" 102 : 203-210, 2000

12 American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders" American Psychiatric Association 2000

13 Kim SW, "Concurrent validity of the Korea version of self-reported questionnaire" 16 : 172-179, 1995

14 Morisky DE, "Concurrent and predictive validity of a self-reported measure of medication adherence" 24 : 67-74, 1986

15 Kao YC, "Compliance and schizophrenia: the predictive potential of insight into illness, symptoms, and side effects" 51 : 557-565, 2010

16 Pull CB, "Adequacy of the Brief Psychiatric Rating Scale for distinguishing lesser forms of psychopathology" 40 : 167-173, 1977

17 Hogan TP, "A self-report scale predictive of drug compliance in schizophrenics : reliability and discriminative validity" 13 : 177-183, 1983

18 Fialko L, "A large-scale validation study of the Medication Adherence Rating Scale(MARS)" 100 : 53-59, 2008

19 Byerly M, "A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia" 133 : 129-133, 2005